Ameritas Investment Partners, Inc.
Position in JAZZ — Jazz Pharmaceuticals plc
CIK 1055980
LINCOLN, NE
Position in JAZZ
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,116,225
+$223,105 QoQ
Shares Held
11,194
+0.5% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ameritas Investment Partners, Inc. holds $51,229,251 across 215 Biotechnology names. JAZZ ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,563 | $5,609,881 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,656 | $3,597,411 | |
| 3 | EXEL |
Exelixis, Inc.
|
70,554 | $3,026,060 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
36,974 | $2,318,269 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
83,064 | $2,300,872 | |
| 6 | CYTK |
Cytokinetics Inc
|
32,284 | $2,127,838 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
11,194 | $2,116,225 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
35,392 | $1,999,294 |
All Filings in JAZZ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,116,225 | 11,194 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $1,893,120 | 11,136 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $1,498,697 | 11,371 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $1,270,256 | 11,970 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $1,476,764 | 11,895 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $1,491,223 | 12,109 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $1,411,564 | 12,670 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,431,142 | 13,409 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $1,673,958 | 13,901 | Shares | Other | 2024-05-13 | |
| 2023-12-31 | $1,709,823 | 13,901 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $1,832,870 | 14,160 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $1,987,239 | 16,030 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $2,345,669 | 16,030 | Shares | Other | 2023-05-10 | |
| 2022-12-31 | $2,596,115 | 16,296 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $2,148,634 | 16,120 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,592,886 | 16,620 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $2,558,592 | 16,436 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $2,093,946 | 16,436 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $2,115,131 | 16,244 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $2,885,584 | 16,244 | Shares | Other | 2021-08-06 | |
| 2021-03-31 | $2,547,406 | 15,498 | Shares | Other | 2021-05-14 | |
| 2020-12-31 | $2,541,439 | 15,398 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $2,238,805 | 15,701 | Shares | Other | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||